WINDTREE THERAPEUTICS INC /DE/ Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-06-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2025-03-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2020 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2019 was $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $0.00 derived: sum of 2 quarters · filed 2025-11-19 | $0.00 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $0.00 10-Q · filed 2025-08-19 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | ||||
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 | ||||
| 2020-12-01 | $0.00 10-Q · filed 2021-08-05 | ||||
| 2019-12-31 | $0.00 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |